$PLUS

RAIGUEL DARREN S sold $188K of PLUS (indirect holdings)

RAIGUEL DARREN S (CHIEF OPERATING OFFICER) sold 2,000 indirectly-held shares of EPLUS INC (PLUS) at an average of $94.03 ($93.10–$95.35, $0.19M total) across 4 trades over 2026-07-28 to 2026-07-29 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · RAIGUEL DARREN S
Published Jul 30, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 6:09 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PLUS
Neutral
high confidence
Mentioned
$PLUS
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLUSNeutralLow
01

Why it matters

The disclosure updates the record of insider activity and may marginally influence sentiment, but it does not introduce new guidance, contracts, litigation, or operational metrics.

02

Market read

Traders may note the insider sale for sentiment monitoring, but the 10b5-1 structure limits actionable inference.

03

What to watch

The article specifies indirect holdings and a pre-arranged plan, which typically reduces interpretability versus discretionary sales.

Relevance 3/10Novelty 3/10Timing: Filed July 30, covering sales dated July 28 to July 29.

Background

This is an SEC Form 4 insider transaction disclosure for EPLUS INC (PLUS) by its COO, reported via SEC EDGAR.

Company-level read

Ticker impact

$PLUSNeutralHigh confidence
Context

EPLUS COO RAIGUEL DARREN S sold about 2,000 PLUS shares for roughly $188K under a pre-arranged 10b5-1 plan, filed July 30.

Expected impact

Low likelihood of sustained price impact; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction with explicit 10b5-1 pre-arrangement, and the article contains no new company-specific operational or financial developments.

Market effects

No sector-level implications; this is a single-company insider transaction with no stated business catalyst.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated or sizable sales can still reflect personal liquidity needs or reduced conviction, which some traders may front-run.

Key entities

  • PLUS

    EPLUS INC, the company whose insider transaction is disclosed.

  • RAIGUEL DARREN S

    Chief Operating Officer of EPLUS INC, selling shares under a pre-arranged 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CDWMedAI 8/10

Q2 Earnings Outperformers: CDW (NASDAQ:CDW) And The Rest Of The IT Distribution & Solutions Stocks

CDW, ePlus, TD SYNNEX, and ScanSource reported Q2 earnings. CDW (-6%) and ePlus (-10.5%) saw stock declines, while ScanSource (+5.5%) rose. TD SYNNEX (-10.5%) reported strong revenue growth but also fell. ePlus reported flat revenue but beat EPS estimates. ScanSource had the largest analyst estimate beat. TD SYNNEX reported $19.57B revenue, up 31% YoY, and beat EPS estimates and guidance.

$PLUSMed

Plus500 increases buybacks as US growth continues

Plus500 said it will increase shareholder returns via buybacks alongside its half-year results. The company reported double-digit revenue growth year over year and Ebitda up 1% to $188mn. It attributed a lower Ebitda margin (45% to 41%) to higher marketing spend to attract new customers, while expanding in US futures.

$PLUSMedAI 8/10

Why ePlus (PLUS) Shares Are Plunging Today

ePlus (NASDAQ: PLUS) shares fell about 5% after the company reported Q2 2026 results. Revenue rose 1.9% year over year to $649.1 million and adjusted EPS was $1.28, both above Wall Street estimates. Despite the beat, investors focused on declining adjusted operating and free cash flow margins and a forecast of about 2% full-year EPS growth. Shares later traded near $92.31.